Last checked at 
LONDON (Alliance News) - Cancer drug discovery and development company Sareum Holdings PLC on Thursday said its equity swap deal with YA Global Master SPV Ltd has concluded ahead of schedule.
Sareum said YA Global Master will remain an ordinary shareholder in the company, with a 1.15% stake, but said there are no further obligations under the equity swap agreement.
"We appreciate YA Global Master's support of Sareum and are pleased to have satisfactorily concluded this agreement," said Sareum Chief Executive Tim Mitchell.
Shares in Sareum were up 20% to 0.389 pence on Thursday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
